120 related articles for article (PubMed ID: 22137144)
1. Carnosine inhibits KRAS-mediated HCT116 proliferation by affecting ATP and ROS production.
Iovine B; Iannella ML; Nocella F; Pricolo MR; Bevilacqua MA
Cancer Lett; 2012 Feb; 315(2):122-8. PubMed ID: 22137144
[TBL] [Abstract][Full Text] [Related]
2. The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells.
Iovine B; Oliviero G; Garofalo M; Orefice M; Nocella F; Borbone N; Piccialli V; Centore R; Mazzone M; Piccialli G; Bevilacqua MA
PLoS One; 2014; 9(5):e96755. PubMed ID: 24804733
[TBL] [Abstract][Full Text] [Related]
3. Carnosine inhibits ATP production in cells from malignant glioma.
Renner C; Asperger A; Seyffarth A; Meixensberger J; Gebhardt R; Gaunitz F
Neurol Res; 2010 Feb; 32(1):101-5. PubMed ID: 19909581
[TBL] [Abstract][Full Text] [Related]
4. Carnosine Inhibits the Proliferation of Human Cervical Gland Carcinoma Cells Through Inhibiting Both Mitochondrial Bioenergetics and Glycolysis Pathways and Retarding Cell Cycle Progression.
Bao Y; Ding S; Cheng J; Liu Y; Wang B; Xu H; Shen Y; Lyu J
Integr Cancer Ther; 2018 Mar; 17(1):80-91. PubMed ID: 28008780
[TBL] [Abstract][Full Text] [Related]
5. Carnosine inhibits the proliferation of human gastric cancer SGC-7901 cells through both of the mitochondrial respiration and glycolysis pathways.
Shen Y; Yang J; Li J; Shi X; Ouyang L; Tian Y; Lu J
PLoS One; 2014; 9(8):e104632. PubMed ID: 25115854
[TBL] [Abstract][Full Text] [Related]
6. Esculetin inhibits cell proliferation through the Ras/ERK1/2 pathway in human colon cancer cells.
Park SS; Park SK; Lim JH; Choi YH; Kim WJ; Moon SK
Oncol Rep; 2011 Jan; 25(1):223-30. PubMed ID: 21109980
[TBL] [Abstract][Full Text] [Related]
7. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
Hogan FS; Krishnegowda NK; Mikhailova M; Kahlenberg MS
J Surg Res; 2007 Nov; 143(1):58-65. PubMed ID: 17950073
[TBL] [Abstract][Full Text] [Related]
8. Role of p21CIP1 as a determinant of SC-560 response in human HCT116 colon carcinoma cells.
Lee E; Choi MK; Han IO; Lim SJ
Exp Mol Med; 2006 Jun; 38(3):325-31. PubMed ID: 16819292
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of natural dipeptide carnosine against human cervical carcinoma cells.
Pandurangan M; Enkhtaivan G; Kim DH
J Mol Recognit; 2016 Sep; 29(9):426-35. PubMed ID: 27000946
[TBL] [Abstract][Full Text] [Related]
10. [Increased manganese superoxide dismutase and cyclin B1 expression in carnosine-induced inhibition of glioblastoma cell proliferation].
Rybakova YS; Kalen AL; Eckers JC; Fedorova TN; Goswami PC; Sarsour EH
Biomed Khim; 2015; 61(4):510-8. PubMed ID: 26350743
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of diallyl disulfide in cell cycle arrest and apoptosis in HCT-116 colon cancer cells.
Song JD; Lee SK; Kim KM; Park SE; Park SJ; Kim KH; Ahn SC; Park YC
J Biochem Mol Toxicol; 2009; 23(1):71-9. PubMed ID: 19202565
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.
Weinberg F; Hamanaka R; Wheaton WW; Weinberg S; Joseph J; Lopez M; Kalyanaraman B; Mutlu GM; Budinger GR; Chandel NS
Proc Natl Acad Sci U S A; 2010 May; 107(19):8788-93. PubMed ID: 20421486
[TBL] [Abstract][Full Text] [Related]
13. c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutation.
Li Y; Wang J; Gao X; Han W; Zheng Y; Xu H; Zhang C; He Q; Zhang L; Li Z; Zhou D
PLoS One; 2014; 9(11):e113186. PubMed ID: 25427200
[TBL] [Abstract][Full Text] [Related]
14. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
15. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
16. The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells.
Dozio E; Ruscica M; Passafaro L; Dogliotti G; Steffani L; Marthyn P; Pagani A; Demartini G; Esposti D; Fraschini F; Magni P
Eur J Pharmacol; 2010 Sep; 641(1):29-34. PubMed ID: 20580704
[TBL] [Abstract][Full Text] [Related]
17. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling.
Wu JR; Liou SF; Lin SW; Chai CY; Dai ZK; Liang JC; Chen IJ; Yeh JL
Pharmacol Res; 2009 Jan; 59(1):48-56. PubMed ID: 18973813
[TBL] [Abstract][Full Text] [Related]
18. [Growth inhibition of combined pathway inhibitors on KRAS mutated non-small cell lung cancer cell line].
Li ZW; Yang ZL; Feng HL; Bian XC; Liu YY; Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):330-5. PubMed ID: 24004591
[TBL] [Abstract][Full Text] [Related]
19. Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines.
Piscazzi A; Costantino E; Maddalena F; Natalicchio MI; Gerardi AM; Antonetti R; Cignarelli M; Landriscina M
J Clin Endocrinol Metab; 2012 Jun; 97(6):E898-906. PubMed ID: 22442268
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumour cell growth by carnosine: some possible mechanisms.
Hipkiss AR; Gaunitz F
Amino Acids; 2014 Feb; 46(2):327-37. PubMed ID: 24292217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
